Cysteine Substitutions in Epidermal Growth Factor–Like Domains of Fibrillin-1: Distinct Effects on Biochemical and Clinical Phenotypes

This publication has 50 references indexed in Scilit:

• Three novel fibrillin mutations in exons 25 and 27: Classic versus neonatal Marfan syndrome
  Human Mutation, 1997
• Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome
  Human Molecular Genetics, 1996
• A Point Mutation Creating an ExtraN-Glycosylation Site in Fibrillin-1 Results in Neonatal Marfan Syndrome
  Genomics, 1996
• Delineation of the Marfan phenotype associated with mutations in exons 23–32 of theFBN1 gene
  American Journal of Medical Genetics, 1996
• Substitution of a cysteine residue in a non-calcium binding, EGF-like domain of fibrillin segregates with the Marfan syndrome in a large kindred
  Human Molecular Genetics, 1994
• A new missense mutation of fibrillin in a patient with Marfan syndrome.
  Journal of Medical Genetics, 1994
• The role of calcium in the organization of fibrillin microfibrils
  FEBS Letters, 1993
• Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome
  Human Molecular Genetics, 1993
• Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene.
  Journal of Clinical Investigation, 1992
• The Marfan Syndrome: Diagnosis and Management
  New England Journal of Medicine, 1979